| NDC Code | 0069-0502-30 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30) |
|---|
| Product NDC | 0069-0502 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Xeljanz |
|---|
| Proprietary Name Suffix | Xr |
|---|
| Non-Proprietary Name | Tofacitinib |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200121 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA208246 |
|---|
| Manufacturer | Pfizer Laboratories Div Pfizer Inc |
|---|
| Substance Name | TOFACITINIB CITRATE |
|---|
| Strength | 22 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA] |
|---|